Nov 9 (Reuters) - Aurinia Pharmaceuticals Inc AUP.TO :
* AURINIA - PRESENTS INTEGRATED TIME TO RENAL RESPONSE DATA FROM AURA-LV & AURORA TRIALS, VOCLOSPORIN DRUG-DRUG INTERACTION DATA AT ACR CONVERGENCE 2020
* AURINIA - INTEGRATED ANALYSIS CONFIRMS VOCLOSPORIN ADDITION TO STANDARD-OF-CARE RESULTED IN FASTER RENAL RESPONSE VERSUS STANDARD-OF-CARE ALONE IN LUPUS NEPHRITIS
* AURINIA PHARMACEUTICALS INC - DDI STUDY DEMONSTRATES NO CLINICALLY MEANINGFUL INTERACTION BETWEEN VOCLOSPORIN AND MMF